In bladder cancer cell lines, TGFβ1 treatment significantly elevated NRP2 mRNA by five-fold while only a minor increase of the NRP2 protein level was observed in our hands [31]. The gene discussed is TGFB1; the disease is urinary bladder carcinoma.